1. Biomarkers in melanoma. (13th July 2016) Authors: Griewank, Klaus G. Journal: Scandinavian journal of clinical & laboratory investigation Issue: Volume 76(2016)Supplement 245 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment. (May 2022) Authors: Lodde, Georg C.; Jansen, Philipp; Möller, Inga; Sucker, Antje; Hassel, Jessica C.; Forschner, Andrea; Eckardt, Julia; Meier, Friedegund; Reinhardt, Lydia; Kähler, Katharina C.; Ziemer, Mirjana; Schlaak, Max; Rahimi, Farnaz; Schatton, Kerstin; Meiss, Frank; Gutzmer, Ralf; Pföhler, Claudia; Terheyd... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High TERT promoter mutation frequency in non‐acral cutaneous metastatic melanoma. (1st August 2016) Authors: Ekedahl, Henrik; Lauss, Martin; Olsson, Håkan; Griewank, Klaus G.; Schadendorf, Dirk; Ingvar, Christian; Jönsson, Göran Journal: Pigment cell & melanoma research Issue: Volume 29:Number 5(2016:Sep.) Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunocytochemical analysis of glucose transporter protein‐1 (GLUT‐1) in typical, brain invasive, atypical and anaplastic meningioma. Issue 1 (28th August 2014) Authors: van de Nes, Johannes A. P.; Griewank, Klaus G.; Schmid, Kurt‐Werner; Grabellus, Florian Journal: Neuropathology Issue: Volume 35:Issue 1(2015) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intraventricular melanocytoma diagnosis confirmed by gene mutation profile. Issue 3 (11th December 2017) Authors: Knappe, Ulrich J.; Tischoff, Iris; Tannapfel, Andrea; Reinbold, Wolf‐Dieter; Möller, Inga; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus G.; van de Nes, Johannes A.P. Journal: Neuropathology Issue: Volume 38:Issue 3(2018) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Melanoma diagnosed in lesions previously treated by laser therapy. Issue 1 (27th June 2016) Authors: Delker, Sarah; Livingstone, Elisabeth; Schimming, Tobias; Schadendorf, Dirk; Griewank, Klaus G. Journal: Journal of dermatology Issue: Volume 44:Issue 1(2017) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors. (December 2021) Authors: Thielmann, Carl M.; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; ... Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oncogene status as a diagnostic tool in ocular and cutaneous melanoma. (April 2016) Authors: Griewank, Klaus G.; Schilling, Bastian; Scholz, Simone L.; Metz, Claudia H.; Livingstone, Elisabeth; Sucker, Antje; Möller, Inga; Reis, Henning; Franklin, Cindy; Cosgarea, Ioana; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zimmer, Lisa Journal: European journal of cancer Issue: Volume 57(2016) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Re: Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images. (May 2020) Authors: Géraud, Cyrill; Griewank, Klaus G. Journal: European journal of cancer Issue: Volume 130(2020) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy. (January 2022) Authors: Thielmann, Carl M.; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichentha... Journal: European journal of cancer Issue: Volume 161(2022) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗